Skip to content
TrialScanner

NCT03185013

REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Phase 3CompletedINOLead

Registry record

Lead sponsor
Inovio Pharmaceuticals
Conditions
Cervical Dysplasia; Cervical High Grade Squamous Intraepithelial Lesion; HSIL
Primary completion
Jul 8, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03185013 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03185013: REVEAL 1 (Evaluation of... | TrialScanner